Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Mass.
Division of Clinical Informatics, Pediatrics, Allergy and Immunology, Liberty University College of Osteopathic Medicine and Collaborative Health Partners, Lynchburg, Va.
J Allergy Clin Immunol. 2024 Jan;153(1):335-340.e1. doi: 10.1016/j.jaci.2023.09.036. Epub 2023 Oct 5.
Racial and ethnic disparities in life expectancy in the United States have been widely documented. To date, there remains a paucity of similar data in patients with inborn errors of immunity (IEIs).
Our aim was to examine racial and ethnic differences in mortality due to an IEI in the United States.
We analyzed National Center for Health Statistics national mortality data from 2003 to 2018. We quantified age-adjusted death rate and age-specific death rate as a result of an IEI for each major racial and ethnic group in the United States and examined the association of race and ethnicity with death at a younger age.
From 2003 to 2018, IEIs were reported as the underlying or contributing cause of death in 14,970 individuals nationwide. The age-adjusted death rate was highest among Black patients (4.25 per 1,000,000 person years), compared with 2.01, 1.71, 1.50, and 0.92 per 1,000,000 person years for White, American Indian/Alaska Native, Hispanic, and Asian/Pacific Islander patients, respectively. The odds of death before age 65 years were greatest among Black patients (odds ratio [OR] = 5.15 [95% CI = 4.61-5.76]), followed by American Indian/Alaska Native patients (OR = 3.58 [95% CI = 2.30-5.82]), compared with White patients. The odds of death before age 24 years were greater among Hispanic patients than among non-Hispanic patients (OR = 3.60 [95% CI = 3.08-4.18]).
Our study highlights racial and ethnic disparities in mortality due to an IEI and the urgent need to further identify and systematically remove barriers in care for historically marginalized patients with IEIs.
美国的预期寿命存在明显的种族和民族差异,这一点已得到广泛证实。迄今为止,在患有先天性免疫缺陷(IEI)的患者中,类似的数据仍然很少。
我们旨在研究美国因 IEI 导致的死亡率的种族和民族差异。
我们分析了 2003 年至 2018 年国家卫生统计中心的国家死亡率数据。我们量化了每个主要种族和族裔群体的年龄调整死亡率和特定年龄的死亡率,作为美国因 IEI 导致的死亡的结果,并研究了种族和民族与早逝之间的关联。
2003 年至 2018 年,IEI 被报告为全国范围内 14970 人的死亡根本或促成原因。黑人患者的年龄调整死亡率最高(每 100 万人中有 4.25 人),而白人、美国印第安人/阿拉斯加原住民、西班牙裔和亚洲/太平洋岛民患者的死亡率分别为每 100 万人中有 2.01、1.71、1.50 和 0.92 人。在 65 岁之前死亡的几率在黑人患者中最高(比值比[OR] = 5.15 [95%置信区间[CI] = 4.61-5.76]),其次是美国印第安人/阿拉斯加原住民患者(OR = 3.58 [95% CI = 2.30-5.82]),而白人患者的几率最低。与非西班牙裔患者相比,西班牙裔患者在 24 岁之前死亡的几率更高(比值比[OR] = 3.60 [95% CI = 3.08-4.18])。
我们的研究强调了因 IEI 导致的死亡率的种族和民族差异,迫切需要进一步确定并系统地消除对历史上处于边缘地位的 IEI 患者护理方面的障碍。